2024年度肾脏病领域高价值论文TOP100
在过去，我们通常通过期刊影响因子或被引频次这样的单一指标来评估一篇论文的价值，但这种方法由于过于偏颇而受到广泛批评。为此，北京同舟云网络信息技术有限公司开发了一种创新的优选算法，它综合考虑了Metrics期刊评分、论文被引频次、文献类型以及论文发表时间等多个因素，对每篇论文进行深入的解析和计算，并为其分配分数，以量化论文的学术价值和影响力。本推荐表基于系统全面准确地统计中国机构作者发表的肾脏病领域国际论文（包括由肾脏病领域专家主要完成的全部论文，不再筛选论文的内容主题），依照上述优选算法对每篇论文进行计算并赋分排名而生成，供相关学者学习、评判、参考和借鉴。
序号 | 年份 | 标题 | 期刊 | 第一作者和共同第一作者 | 通讯作者和共同通迅作者 | 论文评分 | 1 | 2024 | Phase II clinical trial of neoadjuvant anti-PD-1 (toripalimab) combined with axitinib in resectable mucosal melanoma | ANN ONCOL | 1.Wu, N.,北京大学肿瘤医院(1/15);2.Li, M.,北京大学肿瘤医院(2/15); | 1.崔传亮,北京大学,肿瘤医院,黑色素瘤与肉瘤内科(15/15); | 24473.02 | 2 | 2024 | Comparative Effectiveness and Safety of Atorvastatin Versus Rosuvastatin A Multi-database Cohort Study | ANN INTERN MED | 1.Zhou, Shiyu,南方医科大学(1/14); | 1.徐欣,南方医科大学,南方医院,肾内科(13/14);2.聂晟,南方医科大学,南方医院,肾内科(14/14); | 23051.10 | 3 | 2024 | Intestinal CXCR6+ ILC3s migrate to the kidney and exacerbate renal fibrosis via IL-23 receptor signaling enhanced by PD-1 expression | IMMUNITY | 1.Liang, Zhou,中山大学(1/39); | 2.陈崴,中山大学,附属第一医院,肾内科(38/39);1.Joseph V,Bonventre,Harvard University(37/39);3.周怡,中山大学,附属第一医院,肾内科(39/39); | 19183.72 | 4 | 2024 | Anti-nephrin autoantibodies: a paradigm shift in podocytopathies | NAT REV NEPHROL | 1.崔昭,北京大学,第一医院,肾脏内科(1/2); | 1.赵明辉,北京大学,第一医院,肾脏内科(2/2); | 17763.75 | 5 | 2024 | Real-world effectiveness of early insulin therapy on the incidence of cardiovascular events in newly diagnosed type 2 diabetes | SIGNAL TRANSDUCT TAR | 1.骆斯慧,中国科学技术大学,附属第一医院,内分泌科(1/26);2.郑雪瑛,中国科学技术大学,附属第一医院,内分泌科(2/26);3.包巍,中国科学技术大学,生命科学与医学部(3/26); | 1.侯凡凡,南方医科大学,南方医院,肾内科(25/26);2.翁建平,中国科学技术大学,生命科学与医学部(26/26); | 16513.86 | 6 | 2024 | Effect of Delayed Remote Ischemic Preconditioning on Acute Kidney Injury and Outcomes in Patients Undergoing Cardiac Surgery: A Randomized Clinical Trial | CIRCULATION | 1.贾平,复旦大学上海医学院,中山医院,肾内科(1/16); | 3.丁小强,复旦大学,附属中山医院,肾脏内科(16/16);1.罗哲,复旦大学,附属中山医院,重症医学科(14/16);2.王春生,复旦大学,附属中山医院,心脏外科(15/16); | 16490.91 | 7 | 2024 | A Journey of Challenges and Victories: A Bibliometric Worldview of Nanomedicine since the 21st Century | ADV MATER | 1.Wang, Jingyu,北京大学(1/8); | 1.张月苗,北京大学,第一医院,肾内科(8/8); | 14394.94 | 8 | 2024 | Targeted release of budesonide in primary IgA nephropathy | LANCET | 1.Zou, Yonghua,南京医科大学(1/3); | 1.杜新,南京医科大学,附属南京第一医院,肾内科(2/3); | 14291.40 | 9 | 2024 | Targeted release of budesonide in primary IgA nephropathy | LANCET | 1.Hu, Yitong,北京大学第一医院(1/2); | 1.张月苗,北京大学,第一医院,肾内科(2/2); | 14291.40 | 10 | 2024 | IBI310 (anti-CTLA-4 antibody) monotherapy or in combination with sintilimab in advanced melanoma or urothelial carcinoma | INNOVATION-AMSTERDAM | 1.崔传亮,北京大学,肿瘤医院,黑色素瘤与肉瘤内科(1/17);2.Li, Juan,北京大学肿瘤医院(2/17);3.杨跃,北京大学,肿瘤医院,胸部肿瘤外科(3/17); | 1.连斌,北京大学,肿瘤医院,黑色素瘤与肉瘤内科(17/17); | 12362.06 | 11 | 2024 | Reactive Oxygen Species Responsive Multifunctional Fusion Extracellular Nanovesicles: Prospective Treatments for Acute Heart Transplant Rejection | ADV MATER | 1.Lu, Xingyu,中山大学(1/13); | 1.孙其鹏,广东省人民医院,外科,肾移植科(11/13);2.Cheng, Fang,中山大学(12/13);3.陈红波,清华大学,深圳研究生院(13/13); | 12354.94 | 12 | 2024 | Single-cell profiling reveals kidney CD163+ dendritic cell participation in human lupus nephritis | ANN RHEUM DIS | 1.陈崴,中山大学,附属第一医院,肾内科(1/24);2.Jin, Bei,中山大学(2/24);3.Cheng, Cheng,中山大学(3/24);4.Peng, Huajing,中山大学(4/24);5.Zhang, Xinxin,中山大学(5/24);6.檀卫平,中山大学,孙逸仙纪念医院,儿科风湿免疫专科(6/24); | 1.陈崴,中山大学,附属第一医院,肾内科(1/24);2.周怡,中山大学,附属第一医院,肾内科(22/24);3.Wang, Fang,中山大学,附属第一医院(23/24);4.蒋小云,中山大学,附属第一医院,儿科一科(24/24); | 11029.82 | 13 | 2024 | Carbon modification facilitates piezocatalytic H2O2 production over BiOCl nanosheets: Correlation between piezoresponse and surface reaction | APPL CATAL B-ENVIRON | 1.Zhou, Yuanyi,暨南大学(1/6);2.Dong, Haojie,暨南大学(2/6); | 2.孟宇,暨南大学,附属第一医院,肾内科(6/6);1.朱明山,暨南大学,环境学院(5/6); | 10734.91 | 14 | 2024 | Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy | KIDNEY INT | 1.张宏,北京大学,第一医院,肾脏内科(1/16); | 1.张宏,北京大学,第一医院,肾脏内科(1/16); | 10301.46 | 15 | 2024 | Superhydrophobic Surface-Assisted Preparation of Microspheres and Supraparticles and Their Applications | NANO-MICRO LETT | 1.Pan, Mengyao,中国电子科技大学(1/14); | 3.邓菲,四川省人民医院,肾内科(14/14);1.王德辉,电子科技大学,基础与前沿研究院(12/14);2.邓旭,电子科技大学,基础与前沿研究院(13/14); | 10248.48 | 16 | 2024 | Integrated multi-omics with machine learning to uncover the intricacies of kidney disease | BRIEF BIOINFORM | 1.Liu, Xinze(1/7); | 1.卓莉,中日友好医院,肾病科(7/7); | 8718.56 | 17 | 2024 | Depleting profibrotic macrophages using bioactivated in vivo assembly peptides ameliorates kidney fibrosis | CELL MOL IMMUNOL | 1.Qing, Ouyang,中国人民解放军总医院(1/19);2.Wang, Chao,中国人民解放军总医院(2/19);3.Sang, Tian,中国人民解放军总医院(3/19);4.Tong, Yan,中国人民解放军总医院(4/19); | 2.蔡广研,解放军总医院,第一医学中心,肾脏病医学部(17/19);1.Qing, Ouyang,中国人民解放军总医院(1/19);3.李莉莉,中国科学院,国家纳米科学中心(北京）(18/19);4.陈香美,解放军总医院,第一医学中心,肾科(19/19); | 8473.54 | 18 | 2024 | A preference-approval structure-based non-additive three-way group consensus decision-making approach for medical diagnosis | INFORM FUSION | 1.Ye, Jin,西安电子科技大学(1/6); | 4.包崑,广东省中医院,肾病科(6/6);1.孙秉珍,西安电子科技大学,经济与管理学院(2/6);2.Bai, Juncheng,西安电子科技大学(3/6);3.楚晓丽,西安电子科技大学,经济与管理学院(5/6); | 8193.78 | 19 | 2024 | A Versatile Passivated Protein-Adsorption Platform for Rapid Healing of Vascular Stents by Modulating the Microenvironment | ADV FUNCT MATER | 1.Li, Linhua,四川大学,生物材料工程研究中心(1/10); | 1.付平,四川大学,华西医院,肾脏内科(9/10);2.王云兵,四川大学,生物医学工程学院(10/10); | 7801.62 | 20 | 2024 | The glycolytic enzyme PFKFB3 drives kidney fi brosis through promoting histone lactylation-mediated NF-kB k B family activation | KIDNEY INT | 1.Wang, Yating,中山大学(1/16); | 1.陈崴,中山大学,附属第一医院,肾内科(14/16);2.刘庆华,中山大学,附属第一医院,肾内科(15/16);3.毛海萍,中山大学,附属第一医院,肾内科(16/16); | 7661.46 | 21 | 2024 | Platelet-inspired nanomedicine targeting activated neutrophils to alleviate ulcerative colitis by free radicals scavenging and controlled neutrophil swarming | NANO TODAY | 1.Yan, Xiangji,河北大学(1/11);2.Song, Jian,广西医学科学院(2/11); | 1.丁晨光,西安交通大学,第一附属医院,肾移植科(9/11);2.张明真,西安交通大学,医学部,生物医学工程(10/11);3.Zhang, Bao jun,西安交通大学(11/11); | 7550.04 | 22 | 2024 | Chronic kidney disease in a murine model of non-alcoholic steatohepatitis[NASH] | KIDNEY INT | 1.李雪竹,上海交通大学医学院,第九人民医院,肾脏内科(1/10);2.Bhattacharya, Dipankar,Icahn School Medicine Mount Sinai(2/10);3.Yuan, Yue,上海交通大学(3/10); | 1.Scott L,Friedman,Icahn School of Medicine at Mount Sinai(9/10);2.John Cijiang,He,Icahn School of Medicine at Mount Sinai,NEPHROL(10/10); | 7421.46 | 23 | 2024 | Long-term impact of type 2 diabetes onset on dementia incidence rate among New Zealanders with impaired glucose tolerance: A tapered-matched landmark analysis over 25 years | ALZHEIMERS DEMENT | 1.Yu, Dahai,郑州大学(1/12); | 2.赵占正,郑州大学,第一附属医院,肾脏内科(11/12);1.Yu, Dahai,郑州大学(1/12);3.David,Simmons,University of Western Sydney(12/12); | 7203.45 | 24 | 2024 | STING antagonist-loaded renal tubule epithelial cell-mimicking nanoparticles ameliorate acute kidney injury by orchestrating innate and adaptive immunity | NANO TODAY | 1.Shen, Yuqi,上海交通大学(1/11); | 2.丁峰,上海交通大学医学院,第九人民医院,肾脏内科(10/11);1.Wang, Lu,上海交通大学,附属仁济医院,上海市核酸化学与纳米医学重点实验室(9/11);3.刘尽尧,上海交通大学医学院,仁济医院,分子医学研究院(11/11); | 6950.04 | 25 | 2024 | rs-TAC PDC, a peptide drug-conjugate, for targeted delivery of tacrolimus and sericin alleviates podocyte injury in diabetic nephropathy | NANO TODAY | 1.Gao, Shaohui,南京大学(1/17); | 1.刘志红,东部战区总医院,肾脏病科(16/17);2.鲍浩,东部战区总医院,肾脏病科(17/17); | 6830.04 | 26 | 2024 | Disrupting circadian control of autophagy induces podocyte injury and proteinuria | KIDNEY INT | 1.Wang, Lulu,南京医科大学(1/12); | 1.方丽,南通大学,附属医院,肾脏内科(9/12);2.Zhou, Yang,南京医科大学(10/12);3.杨俊伟,南京医科大学,第二附属医院,肾脏病中心(11/12);4.江蕾,南京医科大学,附属第二医院,肾脏内科(12/12); | 6821.46 | 27 | 2024 | Tauroursodeoxycholic acid ameliorates renal injury induced by COL4A3 mutation | KIDNEY INT | 1.Yu, Shuwen,上海交通大学(1/17);2.顾向晨,上海中医药大学,附属岳阳中西医结合医院,肾病内科(2/17);3.Zheng, Qimin,上海交通大学(3/17); | 2.谢静远,上海交通大学医学院,瑞金医院,肾脏内科(17/17);1.Jin, Yuanmeng,上海交通大学(16/17); | 6821.46 | 28 | 2024 | Novel mitophagy inducer alleviates lupus nephritis by reducing myeloid cell activation and autoantigen presentation | KIDNEY INT | 1.Wang, Huijing,浙江大学(1/13); | 2.韩飞,浙江大学,附属第一医院,肾脏病中心(13/13);1.Xiao, Liang,浙江大学(12/13); | 6701.46 | 29 | 2024 | Association of Body Weight Time in Target Range With the Risk of Kidney Outcomes in Patients With Overweight/Obesity and Type 2 Diabetes Mellitus | DIABETES CARE | 1.Zu, Cheng,南方医科大学(1/13); | 1.秦献辉,南方医科大学,南方医院,肾病内科(13/13); | 6491.82 | 30 | 2024 | Catalytically Self-Supplied Oxygen to Alleviate Hypoxia for Treatment of Acute Kidney Injury | ADV FUNCT MATER | 1.Wang, Tingting,空军军医大学(1/12); | 3.刘宏宝,空军军医大学,唐都医院,肾脏内科(12/12);1.瞿永泉,西北工业大学,化学与化工学院,化学研究中心(10/12);2.田志敏,西北工业大学,化学与化工学院,先进化工研究中心(11/12); | 6481.62 | 31 | 2024 | Single-cell RNA sequencing reveals transdifferentiation of parathyroid chief cells into oxyphil cells in patients with uremic secondary hyperparathyroidism | KIDNEY INT | 1.Mao, Jianping,复旦大学(1/9); | 1.陈靖,复旦大学,附属华山医院,肾病科(8/9); | 6461.46 | 32 | 2024 | Transcription factor Twist1 drives fi broblast activation to promote kidney fi brosis via signaling proteins Prrx1/TNC | KIDNEY INT | 1.Sun, Lianqin,南京医科大学(1/13);2.Liu, Lishan,南京医科大学(2/13); | 1.毛慧娟,南京医科大学,第一附属医院,肾内科(11/13);2.邢昌赢,南京医科大学,第一附属医院,肾内科(12/13);3.Ren, Jiafa,南京医科大学(13/13); | 6461.46 | 33 | 2024 | The Difference Between Cystatin C- and Creatinine-Based Estimated Glomerular Filtration Rate and Risk of Diabetic Microvascular Complications Among Adults With Diabetes: A Population-Based Cohort Study | DIABETES CARE | 1.He, Daijun,北京大学第一医院(1/6); | 1.高碧霞,北京大学,第一医院,肾脏内科(2/6);2.张路霞,北京大学,人工智能研究院,健康医疗大数据国家医疗研究院(6/6); | 6371.82 | 34 | 2024 | Dynamically visualizing profibrotic maladaptive repair after acute kidney injury by fibroblast activation protein imaging | KIDNEY INT | 1.Huang, Jiawen,南方医科大学(1/15); | 2.曹维,南方医科大学,南方医院,肾内科(15/15);1.唐刚华,南方医科大学,南方医院,核医学科(14/15); | 6341.46 | 35 | 2024 | Association of accelerometer-measured physical activity and its change with progression to chronic kidney disease in adults with type 2 diabetes and overweight/obesity | BRIT J SPORT MED | 1.Liu, Mengyi,南方医科大学,南方医院,国家肾脏病临床医学研究中心(1/10); | 1.侯凡凡,南方医科大学,南方医院,肾内科(9/10);2.秦献辉,南方医科大学,南方医院,肾病内科(10/10); | 6340.00 | 36 | 2024 | The secreted micropeptide C4orf48 enhances renal fibrosis via an RNA-binding mechanism | J CLIN INVEST | 1.Yang, Jiayi,中山大学(1/22);2.Zhuang, Hongjie,中山大学(2/22);3.Jinhua,Li,MONASH University(3/22); | 2.余学清,广东省人民医院,肾内科(22/22);1.Jinhua,Li,MONASH University(3/22); | 6279.42 | 37 | 2024 | Fabrication of polymeric microspheres for biomedical applications | MATER HORIZ | 1.Li, Xuebing,中国电子科技大学(1/9);2.Li, Luohuizi,中国电子科技大学(2/9); | 3.邓菲,四川省人民医院,肾内科(9/9);1.Luo, Jing,中国电子科技大学(7/9);2.邓旭,电子科技大学,基础与前沿研究院(8/9); | 5924.34 | 38 | 2024 | Epidemiology, clinical features, risk factors, and outcomes in anti-glomerular basement membrane disease: A systematic review and meta-analysis | AUTOIMMUN REV | 1.Kuang, Huang,北京大学第一医院(1/5); | 1.贾晓玉,北京大学,第一医院,肾脏内科(3/5); | 5646.47 | 39 | 2024 | Clinical phenotype of AAV, anti-GBM disease and double-positive patients after SARS-CoV-2 vaccination | AUTOIMMUN REV | 1.Li, Yisha,中国人民解放军总医院(1/6);2.Wang, Jie,中国人民解放军总医院(2/6); | 1.蔡广研,解放军总医院,第一医学中心,肾脏病医学部(6/6); | 5430.47 | 40 | 2024 | The role of innate immunity in diabetic nephropathy and their therapeutic consequences | J PHARM ANAL | 1.Yang, Min,华中科技大学(1/2); | 1.张春,华中科技大学,附属协和医院,肾内科(2/2); | 5379.07 | 41 | 2024 | The SGLT2 inhibitor dapagliflozin ameliorates renal fibrosis in hyperuricemic nephropathy | CELL REP MED | 1.Hu, Hongtu,武汉大学(1/9); | 2.梁伟,武汉大学,人民医院,肾病内Ⅰ科(8/9);1.Zhou, Ying,首都医科大学(7/9);3.Cao, Yun,海南医科大学(9/9); | 5360.48 | 42 | 2024 | Sensing of mitochondrial DNA by ZBP1 promotes RIPK3-mediated necroptosis and ferroptosis in response to diquat poisoning | CELL DEATH DIFFER | 1.Lai, Kunmei,福建医科大学(1/12);2.Wang, Junjie,福建医科大学(2/12);3.Lin, Siyi,福建医科大学(3/12); | 3.许艳芳,福建医科大学,附属第一医院,肾内科(12/12);1.Wu, Jianfeng,厦门大学,细胞应激生物学(10/12);2.Ma, Huabin,福建医科大学(11/12); | 5248.88 | 43 | 2024 | Renin-angiotensin system inhibitors and risk of hepatocellular carcinoma among patients with hepatitis B virus infection | CAN MED ASSOC J | 1.Chen, Ruixuan,南方医科大学(1/15); | 1.聂晟,南方医科大学,南方医院,肾内科(15/15); | 5187.49 | 44 | 2024 | Kim-1 targeted black phosphorus nanoplatforms: Antioxidation and efferocytosis recovery for acute kidney injury treatment | CHEM ENG J | 1.Wang, Zhiwen,华中科技大学(1/9); | 1.张春,华中科技大学,附属协和医院,肾内科(9/9); | 5140.36 | 45 | 2024 | Toward separation and purification of chlorogenic acid from Lonicerae Japonicae Flo (honeysuckle) using melamine-formaldehyde aerogel: A green and efficient approach | CHEM ENG J | 1.Zhu, Yong,香港中文大学(1/12); | 1.李海伦,徐州医科大学,大学附属淮安医院,肾内科(9/12);2.Hirao, Hajime,香港中文大学（深圳）,Organic Chemistry(10/12);3.He, Yisheng,香港中文大学(11/12);4.Chen, Jihang,香港中文大学(12/12); | 5140.36 | 46 | 2024 | Macrophage autophagy protects against acute kidney injury by inhibiting renal inflammation through the degradation of TARM1 | AUTOPHAGY | 1.Huang, Xiao-Rong,广东药科大学(1/19); | 1.杨陈,广东医科大学,附属医院,肾病研究所(18/19);2.刘华锋,广东医科大学,附属医院,肾病内科(19/19); | 5084.55 | 47 | 2024 | A review regarding the article 'Diabetic peripheral neuropathy is associated with diabetic kidney disease and cardiovascular disease: The silesia diabetes-heart project' | CURR PROB CARDIOLOGY | 1.Ju, Xuegui,四川大学(1/3); | 1.刘芳,四川大学,华西医院,肾脏内科(3/3); | 5026.07 | 48 | 2024 | Automated Electronic Alert for the Care and Outcomes of Adults With Acute Kidney Injury | JAMA NETW OPEN | 1.Li, Ting,南京医科大学(1/13);2.邬步云,南京医科大学,第一附属医院,肾内科(2/13); | 1.毛慧娟,南京医科大学,第一附属医院,肾内科(13/13); | 4932.10 | 49 | 2024 | Activation of BK channels prevents diabetes-induced osteopenia by regulating mitochondrial Ca2+ and SLC25A5/ANT2-PINK1-PRKN-mediated mitophagy | AUTOPHAGY | 2.贺海东,复旦大学上海医学院,闵行医院,肾内科(2/9);1.Jiang, Lan,复旦大学(1/9);3.唐余燕,苏州大学,附属第一医院,肾内科(3/9); | 1.李智平,复旦大学上海医学院,儿科医院,临床药学部(7/9);2.Cai, Hui,EMORY University(8/9);3.张雪梅,复旦大学,药学院,药理学与生物化学教研室(9/9); | 4844.55 | 50 | 2024 | Time-Varying Proteinuria and Progression of IgA Nephropathy: A Cohort Study | AM J KIDNEY DIS | 1.Tang, Chen,北京大学,第一医院,肾内科(1/8); | 1.刘立军,北京大学,第一医院,肾脏内科(7/8); | 4823.52 | 51 | 2024 | Deficiency of thiosulfate sulfurtransferase mediates the dysfunction of renal tubular mitochondrial fatty acid oxidation in diabetic kidney disease | CELL DEATH DIFFER | 1.Zhang, Jia Xiu,东南大学(1/8); | 1.马坤岭,浙江大学,附属第二医院,肾脏内科(8/8); | 4768.88 | 52 | 2024 | The IDH1-R132H mutation aggravates cisplatin-induced acute kidney injury by promoting ferroptosis through disrupting NDUFA1 and FSP1 interaction | CELL DEATH DIFFER | 1.Lai, Kunmei,福建医科大学(1/10); | 2.许艳芳,福建医科大学,附属第一医院,肾内科(10/10);1.Tak W,Mak,University of Toronto(9/10); | 4768.88 | 53 | 2024 | Development and validation of an interpretable Markov-embedded multilabel model for predicting risks of multiple postoperative complications among surgical inpatients: a multicenter prospective cohort study | INT J SURG | 1.于晓初,中国医学科学院,北京协和医院,肾内科(1/12);2.Zhang, Luwen,中国医学科学院(2/12); | 1.于晓初,中国医学科学院,北京协和医院,肾内科(1/12);2.姜晶梅,中国医学科学院,基础医学研究所(12/12); | 4677.95 | 54 | 2024 | Circulating Proteins and IgA Nephropathy A Multiancestry Proteome-Wide Mendelian Randomization Study | J AM SOC NEPHROL | 1.Tang, Chen,北京大学,第一医院,肾内科(1/8); | 1.刘立军,北京大学,第一医院,肾脏内科(7/8); | 4670.50 | 55 | 2024 | Single-cell transcriptomics reveals the ameliorative effect of rosmarinic acid on diabetic nephropathy-induced kidney injury by modulating oxidative stress and inflammation | ACTA PHARM SIN B | 1.Chen, Junhui,江西中医药大学(1/13);2.Zhang, Qian,暨南大学(2/13);3.郭吉楠,深圳市人民医院,第二临床医学院,泌尿外科(3/13);4.古迪,广州医科大学,附属第一医院,泌尿外科(4/13); | 1.张欣洲,深圳市人民医院,肾内科(9/13);2.Nie, Sheng,南方医科大学(10/13);3.陈纯波,深圳市人民医院,重症医学科(11/13);4.冯育林,江西中医药大学,中药固体制剂制造技术国家工程研究中心(12/13);5.王继刚,中国中医科学院,中药研究所(13/13); | 4640.95 | 56 | 2024 | Circulating B Cell-Derived Small RNA Delivered by Extracellular Vesicles: A Dialogue Mechanism for Long-Range Targeted Renal Mitochondrial Injury in Obesity | SMALL | 1.Li, Xiaqing,暨南大学(1/17);2.杨华,暨南大学,附属第一医院,普通外科(2/17);3.Ma, Ke,暨南大学(3/17); | 2.尹良红,暨南大学,附属第一医院,肾脏内科(16/17);1.王存川,暨南大学,附属第一医院,肥胖与代谢病外科(15/17);3.孟宇,暨南大学,附属第一医院,肾内科(17/17); | 4619.66 | 57 | 2024 | A commentary on 'Risk factors for incident venous thromboembolism in patients with renal tumor and inferior vena cava tumor thrombus: A retrospective case-control study' | INT J SURG | 1.Feng, Jianan,海南省总医院(1/3); | 1.魏佳莉,海南省人民医院,肾病内科(3/3); | 4557.95 | 58 | 2024 | Glycolysis in Peritubular Endothelial Cells and Microvascular Rarefaction in CKD | J AM SOC NEPHROL | 1.Huang, Yujie(1/9); | 1.侯凡凡,南方医科大学,南方医院,肾内科(8/9);2.曹维,南方医科大学,南方医院,肾内科(9/9); | 4550.50 | 59 | 2024 | The Selective Endothelin Receptor Antagonist SC0062 in IgA Nephropathy | J AM SOC NEPHROL | 1.Heerspink, Hiddo Jan Lambers,University of Groningen(1/23); | 2.陈江华,浙江大学,附属第一医院,肾脏病中心(23/23);1.Heerspink, Hiddo Jan Lambers,University of Groningen(1/23); | 4550.50 | 60 | 2024 | The multilevel extensive diversity across the cynomolgus macaque captured by ultra-deep adaptive immune receptor repertoire sequencing | SCI ADV | 1.Zhu, Yan,南方医科大学(1/13);2.Tang, Haipei,南方医科大学(2/13);3.Xie, Wenxi,南方医科大学(3/13);4.Chen, Sen,南方医科大学(4/13);5.Zeng, Huikun,南方医科大学(5/13); | 2.余学清,广东省人民医院,肾内科(13/13);1.张镇海,南方医科大学,基础医学院(12/13); | 4542.22 | 61 | 2024 | Marrow mesenchymal stem cell mediates diabetic nephropathy progression via modulation of Smad2/3/WTAP/m6A/ENO1 axis | FASEB J | 1.白彝华,昆明医科大学,第二附属医院,肾内科(1/4); | 1.白彝华,昆明医科大学,第二附属医院,肾内科(1/4); | 4533.39 | 62 | 2024 | SPHK1/S1P/S1PR pathway promotes the progression of peritoneal fibrosis by mesothelial-mesenchymal transition | FASEB J | 1.Zhao, Tingting,海军医学大学(1/8);2.Ding, Tao,西藏军区总医院(2/8);3.Sun, Zhengyu,海军医学大学(3/8);4.Shao, Xin,复旦大学(4/8); | 2.郭志勇,海军军医大学,上海长海医院,肾内科(8/8);1.Yuan, Ji-hang,海军医学大学(7/8); | 4533.39 | 63 | 2024 | FTO-mediated m6A modification of serum amyloid A2 mRNA promotes podocyte injury and inflammation by activating the NF-κB signaling pathway | FASEB J | 1.Lang, Yating,山东第一医科大学(1/11);2.Wang, Qimeng,山东大学(2/11); | 1.王荣,山东省立医院,肾内科(10/11);2.吕智美,山东省立医院,肾内科(11/11); | 4533.39 | 64 | 2024 | Scutellarin alleviates renal ischemia-reperfusion injury by inhibiting the MAPK pathway and pro-inflammatory macrophage polarization | FASEB J | 1.Deng, Ge,西安交通大学(1/10); | 1.田普训,西安交通大学,第一附属医院,肾移植科(10/10); | 4533.39 | 65 | 2024 | Klotho-derived peptide 1 inhibits cellular senescence in the fibrotic kidney by restoring Klotho expression via posttranscriptional regulation | THERANOSTICS | 1.Zhang, Xiaoyao,南方医科大学(1/8);2.Li, Li,南方医科大学(2/8); | 1.周丽丽,南方医科大学,南方医院,肾内科(7/8);2.刘友华,南方医科大学,南方医院,器官衰竭防治国家重点实验室(8/8); | 4524.11 | 66 | 2024 | Interplay of lipid metabolism and inflammation in podocyte injury | METABOLISM | 1.Luo, Zilv(1/4);2.陈朝威,武汉大学,人民医院,肾病内Ⅱ科(2/4); | 1.陈朝威,武汉大学,人民医院,肾病内Ⅱ科(2/4);2.丁国华,武汉大学,人民医院,肾病内科(4/4); | 4503.61 | 67 | 2024 | Role of Z-DNA Binding Protein 1 Sensing Mitochondrial Z-DNA and Triggering Necroptosis in Oxalate-Induced Acute Kidney Injury | J AM SOC NEPHROL | 1.陈财铭,福建医科大学,附属第一医院,肾内科(1/13); | 2.许艳芳,福建医科大学,附属第一医院,肾内科(13/13);1.Ma, Huabin,福建医科大学(12/13); | 4430.50 | 68 | 2024 | Lipolysis-Stimulated Lipoprotein Receptor in Proximal Tubule, BMP-SMAD Signaling, and Kidney Disease | J AM SOC NEPHROL | 1.Jiang, Min,山东工程研究中心分子医学肾病(1/14);2.Wang, Xiangdong,滨州医科大学(2/14);3.Chen, Zhenni,滨州医科大学(3/14); | 1.赵升田,山东大学,第二医院,泌尿外科(13/14);2.Gong, Yong feng,WASHINGTON University(14/14); | 4430.50 | 69 | 2024 | GALNT3 in Ischemia-Reperfusion Injury of the Kidney | J AM SOC NEPHROL | 1.Wu, Wenwen,中南大学(1/7); | 2.董政,中南大学,湘雅二医院,肾内科(7/7);1.Cai, Juan,中南大学,湘雅二医院,肾内科(6/7); | 4430.50 | 70 | 2024 | Autoantibodies Targeting Proteasome Subunit Alpha Type 1 in Autoimmune Podocytopathies | J AM SOC NEPHROL | 1.Liu, Huihui,浙江大学,附属儿童医院,国家儿童健康与疾病临床医学研究中心(1/8); | 1.毛建华,浙江大学,附属儿童医院,肾脏内科(7/8);2.叶青,浙江大学,附属儿童医院,实验检验中心(8/8); | 4430.50 | 71 | 2024 | Lactobacillus casei Cell Wall Extract and Production of Galactose-Deficient IgA1 in a Humanized IGHA1 Mouse Model | J AM SOC NEPHROL | 1.Li, Run,北京大学(1/20); | 1.吕继成,北京大学,第一医院,肾脏内科(19/20); | 4430.50 | 72 | 2024 | Prostacyclin Mitigates Renal Fibrosis by Activating Fibroblast Prostaglandin I2 Receptor | J AM SOC NEPHROL | 1.Li, Jing,复旦大学(1/9); | 1.郝传明,复旦大学,附属华山医院,肾病科(9/9); | 4430.50 | 73 | 2024 | Urinary Cytokeratin 20 as a Biomarker for AKI-CKD Transition among Patients with Acute Decompensated Heart Failure and Acute Kidney Injury | J AM SOC NEPHROL | 1.Ouyang, Han,南方医科大学(1/11); | 1.侯凡凡,南方医科大学,南方医院,肾内科(11/11); | 4430.50 | 74 | 2024 | Structural basis for the reaction cycle and transport mechanism of human Na+-sulfate cotransporter NaS1[SLC13A1] | SCI ADV | 1.Chen, Xudong,清华大学(1/16); | 1.蔡广研,解放军总医院,第一医学中心,肾脏病医学部(13/16);2.Zhang, Sensen,清华大学(14/16);3.周博达,清华大学,临床医学院(15/16);4.杨茂君,清华大学,生命科学学院(16/16); | 4422.22 | 75 | 2024 | JMJD3 activation contributes to renal protection and regeneration following acute kidney injury in mice | FASEB J | 1.Yu, Chao,同济大学(1/7);2.Tang, Jinhua,同济大学(2/7); | 1.庄守纲,同济大学,附属东方医院,肾内科(7/7); | 4413.39 | 76 | 2024 | GSK3β: A ray of hope for the treatment of diabetic kidney disease | FASEB J | 1.Liang, Lu-Lu,郑州大学(1/6); | 1.刘东伟,郑州大学,第一附属医院,肾脏内科(5/6);2.刘章锁,郑州大学,第一附属医院,肾脏内科(6/6); | 4413.39 | 77 | 2024 | FTO-mediated m6A mRNA demethylation aggravates renal fibrosis by targeting RUNX1 and further enhancing PI3K/AKT pathway | FASEB J | 1.Wang, Da-Xi,复旦大学(1/7); | 2.方艺,复旦大学,附属中山医院,肾脏内科(7/7);1.Robert J,Walker,University of Otago(6/7); | 4413.39 | 78 | 2024 | A bioactive composite hydrogel dressing that promotes healing of both acute and chronic diabetic skin wounds | BIOACT MATER | 1.尚顺来,中日友好医院,肾脏病科(1/6); | 1.姜世敏,中日友好医院,肾病科(5/6);2.李文歌,中日友好医院,肾病科(6/6); | 4392.10 | 79 | 2024 | Therapeutic potential for renal fibrosis by targeting Smad3-dependent noncoding RNAs | MOL THER | 1.Gu, Yue-Yu,香港中文大学,医学院(1/3); | 1.刘旭生,广东省中医院,肾病科(2/3);2.蓝辉耀,香港中文大学,李嘉诚健康研究中心,肾内科(3/3); | 4354.26 | 80 | 2024 | The role and mechanism of RIPK1 in vascular endothelial dysfunction in chronic kidney disease | FASEB J | 1.Wang, Cheng,山东第一医科大学(1/8); | 1.吕智美,山东省立医院,肾内科(7/8);2.王荣,山东省立医院,肾内科(8/8); | 4293.39 | 81 | 2024 | LncTCONS_00058568 is involved in the pathophysiologic processes mediated by P2X7R in the lower thoracic spinal cord after acute kidney injury | FASEB J | 1.Wang, Yiru,华中科技大学(1/4); | 2.刘清泉,华中科技大学,附属同济医院,肾病内科(3/4);1.陈智,华中科技大学,附属同济医院,老年医学科(2/4); | 4293.39 | 82 | 2024 | GRK5 promoted renal fibrosis via HDAC5/Smad3 signaling pathway | FASEB J | 1.Xiang, Huiling,华中科技大学(1/6); | 1.张春,华中科技大学,附属协和医院,肾内科(6/6); | 4293.39 | 83 | 2024 | m6A demethylase FTO transcriptionally activated by SP1 improves ischemia reperfusion- triggered acute kidney injury by activating Ambra1/ULK1-mediated ULK1-mediated autophagy | FASEB J | 1.陈艳,南昌大学,第二附属医院,肾脏内科(1/6); | 1.黄翀,南昌大学,第二附属医院,肾脏内科(6/6); | 4293.39 | 84 | 2024 | DNA hypomethylation of Syk induces oxidative stress and apoptosis via the PKCβ/P66shc signaling pathway in diabetic kidney disease | FASEB J | 1.Zhang, Rui,四川大学(1/9);2.Qin, Chunmei,四川大学(2/9); | 1.刘芳,四川大学,华西医院,肾脏内科(9/9); | 4293.39 | 85 | 2024 | CD11b deficiency attenuates the ischemia/reperfusion-induced AKI-to-CKD process by regulating macrophage polarization | FASEB J | 1.Zhou, Huili,复旦大学(1/7); | 1.丁小强,复旦大学,附属中山医院,肾脏内科(6/7);2.石一沁,复旦大学上海医学院,中山医院,肾内科(7/7); | 4293.39 | 86 | 2024 | Deficiency of geranylgeranyl biphosphate synthase in kidney tubules causes cystic kidney disease | FASEB J | 1.Shao, Xiaoyan,南京医科大学(1/16); | 2.曹长春,南京医科大学,附属逸夫医院,肾内科(14/16);1.郭保生,南京大学,医学院,骨科(13/16); | 4293.39 | 87 | 2024 | Vitamin D receptor alleviates lipid peroxidation in diabetic nephropathy by regulating ACLY/Nrf2/Keap1 pathway | FASEB J | 1.Zhou, Yueyi,中南大学(1/6); | 1.张浩,中南大学,湘雅三医院,肾病风湿病科(5/6);2.易斌,中南大学,湘雅三医院,肾病风湿病科(6/6); | 4293.39 | 88 | 2024 | c-Cbl induced podocin ubiquitination contributes to the podocytes injury in diabetic nephropathy | FASEB J | 1.Liang, Lulu,郑州大学(1/10);2.He, Mengfei,郑州大学(2/10); | 2.刘东伟,郑州大学,第一附属医院,肾脏内科(9/10);1.Zhou, Sijie,郑州大学(8/10);3.刘章锁,郑州大学,第一附属医院,肾脏内科(10/10); | 4293.39 | 89 | 2024 | Causal relationship between immune cells and the risk of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis: A Mendelian randomization study | FASEB J | 1.Cai, Xiaojing,华中科技大学(1/4); | 1.刘清泉,华中科技大学,附属同济医院,肾病内科(4/4); | 4293.39 | 90 | 2024 | Construction of competitive endogenous RNA network and identification of potential regulatory axis in vascular calcification | FASEB J | 1.Xu, Tongxin,河北医科大学(1/7); | 1.徐金升,河北医科大学,第四医院,肾内科(7/7); | 4293.39 | 91 | 2024 | LncRNA SNHG12 suppresses adipocyte inflammation and insulin resistance by regulating the HDAC9/Nrf2 axis | FASEB J | 1.Huang, Xiaoyan,海南省妇女儿童医学中心(1/10);2.Chen, Jixiong,海南省人民医院(2/10); | 3.何小解,中南大学,湘雅二医院,小儿肾脏病研究室(10/10);1.Ren, Yi,海口市妇幼保健院(8/10);2.向伟,海南省妇幼保健院,儿科(9/10); | 4293.39 | 92 | 2024 | Paricalcitol ameliorates diabetic nephropathy by promoting EETs and M2 macrophage polarization and inhibiting inflammation by regulating VDR/CYP2J2 axis | FASEB J | 1.Tang, Shiqi,中南大学(1/8); | 1.张浩,中南大学,湘雅三医院,肾病风湿病科(7/8);2.刘妍,中南大学,湘雅三医院,肾病风湿病科(8/8); | 4293.39 | 93 | 2024 | Cannabinoid receptor 2 plays a key role in renal fibrosis through inhibiting lipid metabolism in renal tubular cells | METABOLISM | 1.Zhou, Shan,南方医科大学(1/18); | 1.周丽丽,南方医科大学,南方医院,肾内科(18/18); | 4263.61 | 94 | 2024 | Tubular insulin-induced gene 1 deficiency promotes NAD+ consumption and exacerbates kidney fibrosis | EMBO MOL MED | 1.Li, Shumin,南京医科大学(1/6); | 1.黄松明,南京医科大学,南京市儿童医院,肾脏科(5/6);2.Yu, Xiaowen,南京医科大学(6/6); | 4149.61 | 95 | 2024 | CD36 promotes tubular ferroptosis by regulating the ubiquitination of FSP1 in acute kidney injury | GENES DIS | 1.Ma, Yixin,重庆医科大学(1/10);2.Huang, Lili,重庆医科大学(2/10);3.Zhang, Zheng,重庆医科大学(3/10); | 1.廖晓辉,重庆医科大学,附属第二医院,肾内科(10/10); | 4081.66 | 96 | 2024 | Association of handgrip strength and walking pace with incident Parkinson's disease | J CACHEXIA SARCOPENI | 1.Liu, Mengyi,南方医科大学,南方医院,国家肾脏病临床医学研究中心(1/8); | 1.秦献辉,南方医科大学,南方医院,肾病内科(8/8); | 3994.26 | 97 | 2024 | Social Isolation, Loneliness, and Risk of Microvascular Complications Among Individuals With Type 2 Diabetes Mellitus | AM J KIDNEY DIS | 1.梁燕,广州医科大学,附属脑科医院（神经精神研究所）(1/12); | 1.张俊,中山大学,附属第三医院,肾脏内科(11/12);2.Lu,Qi,Tulane University,Public Health(12/12); | 3983.52 | 98 | 2024 | Kidney Outcomes Following Angiotensin Receptor-Neprilysin Inhibitor vs Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy for Thrombotic Microangiopathy | JAMA NETW OPEN | 1.李剑波,中山大学,附属第一医院,肾内科(1/11); | 2.陈崴,中山大学,附属第一医院,肾内科(11/11);1.He, Feng,华南理工大学(10/11); | 3972.10 | 99 | 2024 | MAGL protects against renal fibrosis through inhibiting tubular cell lipotoxicity | THERANOSTICS | 1.Zhou, Shan,南方医科大学(1/22);2.Ling, Xian,南方医科大学(2/22);3.Zhu, Jielin,南方医科大学(3/22);4.Liang, Ye,南方医科大学(4/22);5.Feng, Qijian,南方医科大学(5/22);6.Xie, Chao,佛山市第一人民医院(6/22); | 3.周丽丽,南方医科大学,南方医院,肾内科(22/22);1.Kong, Yaozhong,佛山市第一人民医院(20/22);2.刘友华,南方医科大学,南方医院,器官衰竭防治国家重点实验室(21/22); | 3924.11 | 100 | 2024 | Fisetin ameliorates fibrotic kidney disease in mice via inhibiting ACSL4-mediated tubular ferroptosis | ACTA PHARMACOL SIN | 1.Wang, Bo,四川大学(1/7); | 1.马良,四川大学,华西医院,肾脏内科(7/7); | 3904.27 |
|
|